Clearpoint Historical Balance Sheet

CLPT Stock

USD 13.53 0.25 1.81%

Trend analysis of Clearpoint Neuro balance sheet accounts such as Total Assets of 24.6 M, Short and Long Term Debt Total of 3.4 M or Other Current Liab of 6.7 M provides information on Clearpoint Neuro's total assets, liabilities, and equity, which is the actual value of Clearpoint Neuro to its prevalent stockholders. By breaking down trends over time using Clearpoint Neuro balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Clearpoint Neuro latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Clearpoint Neuro is a good buy for the upcoming year.

Clearpoint Neuro Inventory

3.83 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearpoint Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.

About Clearpoint Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Clearpoint Neuro at a specified time, usually calculated after every quarter, six months, or one year. Clearpoint Neuro Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Clearpoint Neuro and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Clearpoint currently owns. An asset can also be divided into two categories, current and non-current.

Clearpoint Neuro Balance Sheet Chart

At this time, Clearpoint Neuro's Other Current Assets are comparatively stable compared to the past year. Total Liabilities is likely to gain to about 16.1 M in 2025, despite the fact that Net Debt is likely to grow to (15.7 M).

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Clearpoint Neuro assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Clearpoint Neuro books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from Clearpoint Neuro's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Clearpoint Neuro current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearpoint Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.At this time, Clearpoint Neuro's Other Current Assets are comparatively stable compared to the past year. Total Liabilities is likely to gain to about 16.1 M in 2025, despite the fact that Net Debt is likely to grow to (15.7 M).

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	12.0M	13.9M	3.6M	3.4M
Total Assets	55.5M	42.7M	39.2M	24.6M

Short Long Term Debt Total Total Assets

Clearpoint Neuro balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Retained Earnings
Common Stock Shares Outstanding		0.8	0.17	0.58	-0.05	0.85	0.86	0.37	-0.73	-0.63	0.69	0.79	-0.34	0.71	0.93	-0.34	0.16	0.86	0.94	0.9	0.14	0.85	0.79	-0.73	-0.33	0.5
Total Assets	0.8		0.44	0.37	-0.13	0.92	0.66	0.14	-0.87	-0.58	0.96	0.77	-0.15	0.98	0.66	-0.16	0.4	0.86	0.79	0.87	0.26	0.6	1.0	-0.47	-0.14	0.44
Short Long Term Debt Total	0.17	0.44		-0.05	-0.15	0.15	0.26	-0.07	-0.05	-0.26	0.45	0.46	0.04	0.45	0.06	0.02	0.95	0.27	0.09	0.19	0.69	0.16	0.43	-0.07	0.01	0.1
Other Current Liab	0.58	0.37	-0.05		0.74	0.34	0.73	0.67	-0.34	0.1	0.25	0.51	-0.4	0.28	0.71	0.01	-0.04	0.49	0.71	0.36	0.45	0.75	0.35	0.04	0.03	0.07
Total Current Liabilities	-0.05	-0.13	-0.15	0.74		-0.26	0.28	0.72	0.13	0.66	-0.19	0.07	-0.45	-0.17	0.15	0.06	-0.07	-0.04	0.14	-0.26	0.56	0.3	-0.14	0.51	0.07	-0.5
Total Stockholder Equity	0.85	0.92	0.15	0.34	-0.26		0.62	0.02	-0.93	-0.71	0.88	0.64	-0.08	0.9	0.73	-0.14	0.08	0.81	0.84	0.9	-0.07	0.6	0.92	-0.59	-0.13	0.59
Property Plant And Equipment Net	0.86	0.66	0.26	0.73	0.28	0.62		0.61	-0.53	-0.31	0.55	0.87	-0.57	0.54	0.93	-0.2	0.28	0.7	0.87	0.7	0.44	0.99	0.62	-0.5	-0.18	0.2
Current Deferred Revenue	0.37	0.14	-0.07	0.67	0.72	0.02	0.61		-0.09	0.37	0.03	0.43	-0.77	0.03	0.46	-0.38	0.13	0.31	0.41	0.13	0.56	0.62	0.11	-0.12	-0.36	-0.45
Net Debt	-0.73	-0.87	-0.05	-0.34	0.13	-0.93	-0.53	-0.09		0.49	-0.91	-0.51	0.12	-0.9	-0.62	0.16	-0.02	-0.65	-0.71	-0.77	0.04	-0.51	-0.88	0.44	0.15	-0.43
Accounts Payable	-0.63	-0.58	-0.26	0.1	0.66	-0.71	-0.31	0.37	0.49		-0.54	-0.42	-0.25	-0.55	-0.49	0.07	-0.09	-0.57	-0.48	-0.73	0.32	-0.28	-0.58	0.68	0.07	-0.78
Cash	0.69	0.96	0.45	0.25	-0.19	0.88	0.55	0.03	-0.91	-0.54		0.64	-0.08	0.99	0.54	-0.13	0.41	0.69	0.64	0.77	0.23	0.49	0.97	-0.41	-0.12	0.42
Non Current Assets Total	0.79	0.77	0.46	0.51	0.07	0.64	0.87	0.43	-0.51	-0.42	0.64		-0.4	0.64	0.79	-0.12	0.44	0.84	0.77	0.81	0.42	0.84	0.74	-0.48	-0.09	0.26
Non Currrent Assets Other	-0.34	-0.15	0.04	-0.4	-0.45	-0.08	-0.57	-0.77	0.12	-0.25	-0.08	-0.4		-0.08	-0.38	0.4	-0.15	-0.2	-0.39	-0.1	-0.42	-0.56	-0.12	0.31	0.38	0.62
Cash And Short Term Investments	0.71	0.98	0.45	0.28	-0.17	0.9	0.54	0.03	-0.9	-0.55	0.99	0.64	-0.08		0.54	-0.13	0.41	0.75	0.69	0.78	0.24	0.48	0.99	-0.41	-0.13	0.42
Net Receivables	0.93	0.66	0.06	0.71	0.15	0.73	0.93	0.46	-0.62	-0.49	0.54	0.79	-0.38	0.54		-0.18	0.02	0.76	0.93	0.81	0.15	0.95	0.63	-0.57	-0.16	0.44
Common Stock Total Equity	-0.34	-0.16	0.02	0.01	0.06	-0.14	-0.2	-0.38	0.16	0.07	-0.13	-0.12	0.4	-0.13	-0.18		-0.15	-0.2	-0.22	-0.24	-0.09	-0.19	-0.16	0.62	1.0	0.06
Non Current Liabilities Total	0.16	0.4	0.95	-0.04	-0.07	0.08	0.28	0.13	-0.02	-0.09	0.41	0.44	-0.15	0.41	0.02	-0.15		0.24	0.07	0.13	0.78	0.17	0.38	-0.11	-0.16	-0.1
Inventory	0.86	0.86	0.27	0.49	-0.04	0.81	0.7	0.31	-0.65	-0.57	0.69	0.84	-0.2	0.75	0.76	-0.2	0.24		0.87	0.91	0.18	0.68	0.84	-0.53	-0.18	0.46
Other Current Assets	0.94	0.79	0.09	0.71	0.14	0.84	0.87	0.41	-0.71	-0.48	0.64	0.77	-0.39	0.69	0.93	-0.22	0.07	0.87		0.84	0.17	0.87	0.77	-0.55	-0.2	0.4
Other Stockholder Equity	0.9	0.87	0.19	0.36	-0.26	0.9	0.7	0.13	-0.77	-0.73	0.77	0.81	-0.1	0.78	0.81	-0.24	0.13	0.91	0.84		-0.04	0.68	0.86	-0.68	-0.21	0.63
Total Liab	0.14	0.26	0.69	0.45	0.56	-0.07	0.44	0.56	0.04	0.32	0.23	0.42	-0.42	0.24	0.15	-0.09	0.78	0.18	0.17	-0.04		0.36	0.24	0.2	-0.09	-0.38
Property Plant And Equipment Gross	0.85	0.6	0.16	0.75	0.3	0.6	0.99	0.62	-0.51	-0.28	0.49	0.84	-0.56	0.48	0.95	-0.19	0.17	0.68	0.87	0.68	0.36		0.56	-0.49	-0.16	0.21
Total Current Assets	0.79	1.0	0.43	0.35	-0.14	0.92	0.62	0.11	-0.88	-0.58	0.97	0.74	-0.12	0.99	0.63	-0.16	0.38	0.84	0.77	0.86	0.24	0.56		-0.46	-0.15	0.45
Short Term Debt	-0.73	-0.47	-0.07	0.04	0.51	-0.59	-0.5	-0.12	0.44	0.68	-0.41	-0.48	0.31	-0.41	-0.57	0.62	-0.11	-0.53	-0.55	-0.68	0.2	-0.49	-0.46		0.61	-0.38
Common Stock	-0.33	-0.14	0.01	0.03	0.07	-0.13	-0.18	-0.36	0.15	0.07	-0.12	-0.09	0.38	-0.13	-0.16	1.0	-0.16	-0.18	-0.2	-0.21	-0.09	-0.16	-0.15	0.61		0.07
Retained Earnings	0.5	0.44	0.1	0.07	-0.5	0.59	0.2	-0.45	-0.43	-0.78	0.42	0.26	0.62	0.42	0.44	0.06	-0.1	0.46	0.4	0.63	-0.38	0.21	0.45	-0.38	0.07

Click cells to compare fundamentals

Clearpoint Neuro Account Relationship Matchups

Clearpoint Neuro balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	15.8M	20.7M	24.2M	24.6M	27.0M	28.4M
Total Assets	29.6M	65.6M	55.5M	42.7M	39.2M	24.6M
Short Long Term Debt Total	24.2M	12.3M	12.0M	13.9M	3.6M	3.4M
Other Current Liab	1.9M	2.6M	4.3M	4M	6.3M	6.7M
Total Current Liabilities	3.2M	4.8M	6.8M	7.4M	10.4M	10.9M
Total Stockholder Equity	2.4M	48.8M	36.9M	21.2M	25.4M	26.7M
Property Plant And Equipment Net	3.2M	2.8M	2.7M	5.0M	5.1M	5.3M
Current Deferred Revenue	562K	678K	1.1M	2.6M	2.1M	2.2M
Net Debt	4.1M	(41.8M)	(15.6M)	(9.2M)	(16.5M)	(15.7M)
Accounts Payable	300K	427K	272K	393K	1.3M	1.0M
Cash	20.1M	54.1M	27.6M	23.1M	20.1M	14.6M
Non Current Assets Total	4.2M	3.7M	4.3M	6.5M	5.8M	3.1M
Non Currrent Assets Other	648K	644K	581K	495.0K	251K	238.5K
Cash And Short Term Investments	20.1M	54.1M	37.5M	23.1M	20.1M	15.4M
Net Receivables	1.9M	2.3M	2.7M	3.9M	4.7M	4.9M
Common Stock Total Equity	152.4K	170K	237K	246K	221.4K	263.6K
Liabilities And Stockholders Equity	29.6M	65.6M	55.5M	42.7M	39.2M	24.6M
Non Current Liabilities Total	24.0M	12.0M	11.8M	14.1M	3.4M	3.3M
Inventory	3.2M	4.9M	9.3M	7.9M	6.9M	3.8M
Other Current Assets	488K	1.0M	1.7M	1.2M	1.7M	1.8M
Other Stockholder Equity	121.7M	182.5M	187.0M	193.4M	216.5M	129.6M
Total Liab	27.3M	16.8M	18.6M	21.5M	13.8M	16.1M
Property Plant And Equipment Gross	3.1M	2.8M	2.7M	5.9M	6.4M	6.8M
Total Current Assets	25.5M	61.9M	51.2M	36.2M	33.4M	21.6M
Short Term Debt	394K	1.0M	1.1M	424K	557K	529.2K
Common Stock	170K	237K	246K	247K	276K	255.9K
Retained Earnings	(119.5M)	(133.9M)	(150.4M)	(172.5M)	(191.4M)	(200.9M)
Other Assets	722K	3.7M	644K	581K	668.2K	1.3M
Long Term Debt	21.3M	9.8M	9.9M	9.9M	11.4M	8.3M
Long Term Debt Total	2.1M	21.3M	9.8M	9.9M	11.4M	7.9M
Capital Surpluse	117.2M	121.7M	182.5M	187.0M	215.1M	137.6M
Property Plant Equipment	821K	3.1M	2.8M	1.3M	1.4M	1.3M
Other Liab	1.2M	215K	264K	390K	351K	505.7K
Net Tangible Assets	4.6M	2.0M	48.5M	35.9M	41.2M	43.3M
Net Invested Capital	23.7M	58.6M	46.8M	31.1M	25.4M	28.6M
Net Working Capital	22.3M	57.1M	44.4M	28.7M	23.0M	26.8M
Capital Stock	170K	237K	246K	247K	276K	226.1K
Capital Lease Obligations	3.0M	2.4M	2.1M	4.0M	3.6M	2.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Clearpoint Historical Balance Sheet

Clearpoint Neuro Inventory

3.83 Million

About Clearpoint Balance Sheet Analysis

Clearpoint Neuro Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Clearpoint Neuro balance sheet Correlations

Clearpoint Neuro Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Clearpoint Neuro balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Clearpoint Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Common Stock	+ 1.0	Common Stock Total Equity
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Cash And Short Term Investments	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.98	Total Assets

Net Debt	- 0.93	Total Stockholder Equity
Cash	- 0.91	Net Debt
Cash And Short Term Investments	- 0.9	Net Debt
Total Current Assets	- 0.88	Net Debt
Net Debt	- 0.87	Total Assets
Retained Earnings	- 0.78	Accounts Payable